Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma
Hyungwoo CHO; Dok-Hyun YOON; Jwa-Hoon KIM; Young-Bo KO; Byoung-Soo KWON; In-Hye SONG; Cheolwon SUH.
The Korean Journal of Internal Medicine
; : 605-607, 2016.
Artículo en Inglés | WPRIM | ID: wpr-48489
Documentos relacionados
Vitreous Humor Proteomic Profile in Patients With Vitreoretinal Lymphoma.
[Clinical analysis of 7 cases of pregnancy with non-Hodgkin lymphoma].
The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship.
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
A case of non-Hodgkin lymphoma of the upper gingiva with minimal residual disease detected in cryopreserved ovarian tissue: A case report.
Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature.
Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition.
[Epigenetic abnormalities in non-Hodgkin lymphomas].
[Expression and significance of jumonji domain-containing protein 2B and hypoxia inducible factor-1α in non-Hodgkin lymphoma tissues in children].
MDSCs and T cells in solid tumors and non-Hodgkin lymphomas: an immunosuppressive speech.